Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Solid-State NMR Studies Reveal Native-like β-Sheet Structures in Transthyretin Amyloid.

Lim KH, Dasari AK, Hung I, Gan Z, Kelly JW, Wright PE, Wemmer DE.

Biochemistry. 2016 Sep 20;55(37):5272-8. doi: 10.1021/acs.biochem.6b00649. Epub 2016 Sep 7.

2.

Structural Changes Associated with Transthyretin Misfolding and Amyloid Formation Revealed by Solution and Solid-State NMR.

Lim KH, Dasari AK, Hung I, Gan Z, Kelly JW, Wemmer DE.

Biochemistry. 2016 Apr 5;55(13):1941-4. doi: 10.1021/acs.biochem.6b00164. Epub 2016 Mar 23.

3.

Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.

Lim KH, Dasari AKR, Ma R, Hung I, Gan Z, Kelly JW, Fitzgerald MC.

Biochemistry. 2017 Sep 12;56(36):4808-4818. doi: 10.1021/acs.biochem.7b00658. Epub 2017 Aug 30.

4.
5.

Experimentally derived structural constraints for amyloid fibrils of wild-type transthyretin.

Bateman DA, Tycko R, Wickner RB.

Biophys J. 2011 Nov 16;101(10):2485-92. doi: 10.1016/j.bpj.2011.10.009. Epub 2011 Nov 15.

6.

Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril.

Jaroniec CP, MacPhee CE, Astrof NS, Dobson CM, Griffin RG.

Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16748-53. Epub 2002 Dec 12.

7.

Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin.

Cordeiro Y, Kraineva J, Suarez MC, Tempesta AG, Kelly JW, Silva JL, Winter R, Foguel D.

Biophys J. 2006 Aug 1;91(3):957-67. Epub 2006 May 12.

8.

High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy.

Jaroniec CP, MacPhee CE, Bajaj VS, McMahon MT, Dobson CM, Griffin RG.

Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):711-6. Epub 2004 Jan 8.

9.

Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy.

Olofsson A, Ippel JH, Wijmenga SS, Lundgren E, Ohman A.

J Biol Chem. 2004 Feb 13;279(7):5699-707. Epub 2003 Nov 6.

10.

Accurate determination of interstrand distances and alignment in amyloid fibrils by magic angle spinning NMR.

Caporini MA, Bajaj VS, Veshtort M, Fitzpatrick A, MacPhee CE, Vendruscolo M, Dobson CM, Griffin RG.

J Phys Chem B. 2010 Oct 28;114(42):13555-61. doi: 10.1021/jp106675h.

11.

Localized structural fluctuations promote amyloidogenic conformations in transthyretin.

Lim KH, Dyson HJ, Kelly JW, Wright PE.

J Mol Biol. 2013 Mar 25;425(6):977-88. doi: 10.1016/j.jmb.2013.01.008. Epub 2013 Jan 11.

13.

Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro.

Colon W, Kelly JW.

Biochemistry. 1992 Sep 15;31(36):8654-60.

PMID:
1390650
14.

Higher order amyloid fibril structure by MAS NMR and DNP spectroscopy.

Debelouchina GT, Bayro MJ, Fitzpatrick AW, Ladizhansky V, Colvin MT, Caporini MA, Jaroniec CP, Bajaj VS, Rosay M, Macphee CE, Vendruscolo M, Maas WE, Dobson CM, Griffin RG.

J Am Chem Soc. 2013 Dec 26;135(51):19237-47. doi: 10.1021/ja409050a. Epub 2013 Dec 13.

15.
17.
18.

Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid.

Kelly JW, Colon W, Lai Z, Lashuel HA, McCulloch J, McCutchen SL, Miroy GJ, Peterson SA.

Adv Protein Chem. 1997;50:161-81. Review.

PMID:
9338081
19.

Supplemental Content

Support Center